IL159993A0 - Platinum complexes and their use in cancer treatment - Google Patents

Platinum complexes and their use in cancer treatment

Info

Publication number
IL159993A0
IL159993A0 IL15999302A IL15999302A IL159993A0 IL 159993 A0 IL159993 A0 IL 159993A0 IL 15999302 A IL15999302 A IL 15999302A IL 15999302 A IL15999302 A IL 15999302A IL 159993 A0 IL159993 A0 IL 159993A0
Authority
IL
Israel
Prior art keywords
platinum complexes
cancer treatment
present
concerns novel
novel platinum
Prior art date
Application number
IL15999302A
Other languages
English (en)
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Publication of IL159993A0 publication Critical patent/IL159993A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
IL15999302A 2001-08-23 2002-08-21 Platinum complexes and their use in cancer treatment IL159993A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31411501P 2001-08-23 2001-08-23
PCT/IL2002/000687 WO2003017998A1 (fr) 2001-08-23 2002-08-21 Complexes de platine et utilisation de ceux-ci dans le traitement du cancer

Publications (1)

Publication Number Publication Date
IL159993A0 true IL159993A0 (en) 2004-06-20

Family

ID=23218625

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15999302A IL159993A0 (en) 2001-08-23 2002-08-21 Platinum complexes and their use in cancer treatment

Country Status (9)

Country Link
US (1) US7122668B2 (fr)
EP (1) EP1420775B1 (fr)
JP (1) JP2005501859A (fr)
AT (1) ATE457992T1 (fr)
CA (1) CA2456348A1 (fr)
DE (1) DE60235375D1 (fr)
ES (1) ES2339228T3 (fr)
IL (1) IL159993A0 (fr)
WO (1) WO2003017998A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
EP1617808A4 (fr) 2003-04-25 2011-11-02 Penn State Res Found Methode et systeme de liberation systemique de composes bioactifs derives de lipides, d'arret de croissance
JP2007512318A (ja) * 2003-11-25 2007-05-17 プラトコ・テクノロジーズ・(プロプライエタリー)・リミテッド 白金(ii)錯体並びに該錯体の製法及び使用
CN101018797A (zh) 2004-09-01 2007-08-15 普拉托技术(私有)有限公司 铂(ⅱ)配合物的制备
ES2257178B1 (es) * 2004-09-30 2007-08-16 Universidad Autonoma De Madrid Compuestos de platino de formula trans-(ptc12(isopropilamina)(4-(hidroximetil)-piridina)) y trans-(ptc12(isopropilamina)(3-hidroximetil)-piridina y su aplicacion como farmaco antitumoral.
KR20080096682A (ko) * 2006-01-30 2008-10-31 플라트코 테크놀로지스 (프로프라이어터리) 리미티드 백금(ⅱ) 착물의 제조법
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
WO2010027428A1 (fr) 2008-08-26 2010-03-11 Massachusetts Institute Of Technology Complexes de platine (iv) pour utilisation dans une thérapie pharmaceutique en mode double
CA2839552A1 (fr) 2011-06-21 2012-12-27 Massachusetts Institute Of Technology Compositions et procedes de traitement du cancer
EP2753628A4 (fr) * 2011-08-26 2015-03-11 Univ California Agents anticancéreux du platine
US9133225B2 (en) 2013-03-13 2015-09-15 Massachusetts Institute Of Technology Dual targeting anticancer agents
US9593139B2 (en) 2013-04-05 2017-03-14 Massachusetts Institute Of Technology Compositions, methods, and kits comprising platinum compounds associated with a ligand comprising a targeting moiety
CN103360431B (zh) * 2013-07-16 2015-07-01 山西大学 一种以8-氨基喹哪啶为母体的金属配合物及其合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7304882A (fr) * 1972-04-10 1973-10-12
CA1327039C (fr) * 1986-12-18 1994-02-15 Tetsushi Totani Complexes ammine-amine alicyclique-platine et leur utilisation comme agents antitumoraux
JPS63264492A (ja) * 1986-12-18 1988-11-01 Shionogi & Co Ltd アンミン−脂環系アミン白金錯体および抗腫瘍剤
US4921963A (en) * 1987-04-13 1990-05-01 British Columbia Cancer Foundation Platinum complexes with one radiosensitizing ligand
US5026694A (en) * 1987-04-13 1991-06-25 The British Columbia Cancer Foundation Platinum complexes with one radiosensitizing ligand
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
US7271161B2 (en) * 2002-09-11 2007-09-18 Board Of Regents, The University Of Texas System Platinum complexes as antitumor agents in combination with biochemical modulation

Also Published As

Publication number Publication date
EP1420775A1 (fr) 2004-05-26
US7122668B2 (en) 2006-10-17
WO2003017998B1 (fr) 2003-08-28
JP2005501859A (ja) 2005-01-20
WO2003017998A1 (fr) 2003-03-06
ATE457992T1 (de) 2010-03-15
DE60235375D1 (de) 2010-04-01
EP1420775B1 (fr) 2010-02-17
ES2339228T3 (es) 2010-05-18
CA2456348A1 (fr) 2003-03-06
US20050090478A1 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
IL159993A0 (en) Platinum complexes and their use in cancer treatment
MY126527A (en) Novel dihydropyrimidines
MXPA03006055A (es) Nuevos compuestos de n-fenilpirrolbisfosfano y sus complejos de metal.
UA88645C2 (ru) Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей
GEP20053488B (en) Novel Spiro Compounds
BG105783A (en) Triazole compounds with dopamine-d3-receptor affinity
TW200505875A (en) Novel compounds
TR200103525T2 (tr) Bisiklik poliaminosit metal kompleksleri, bunları hazırlamak için yöntem ve bunların tıbbi görüntülemede kullanımı.
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
GB0111186D0 (en) Novel compounds
MXPA04003796A (es) Tioacetamidas sustituidas.
ZA200500908B (en) Ruthenium anticancer complexes
MX272108B (es) Heterociclos sustituidos.
IL156774A0 (en) Inhibitors of cruzipain and other cysteine proteases
TW200602076A (en) O, O'-amidomalonate and N, O-amidomalonate platinum complexes
PL374080A1 (en) Processes for the preparation of fibrinogen
YU68702A (sh) Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka
MY134026A (en) ?-carboline derivatives and its pharmaceutical use against depression and anxiety
DE60121804D1 (de) Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin
HUP0402165A2 (hu) Nem neurotoxikus plazminogén aktiváló faktorok a szélhűdés kezelésére
EP1601756A4 (fr) Methodes et compositions de traitement du cancer et de maladies infectieuses utilisant des complexes de molecules antigenes d'alpha (2) macroglobuline
MXPA04001419A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson.
MXPA04001655A (es) Derivados de acido ascorbico, metodos de sintesis y uso farmaceutico de los mismos.
AU6011001A (en) Novel lhrh-antagonists, production and use thereof as medicament
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed